Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Stage II Breast Cancer|Stage III Breast Cancer
Interventions: DRUG: fluorouracil|DRUG: capecitabine|DRUG: cyclophosphamide|DRUG: Epirubicin
Sponsor: Guangxi Medical University